Abstract
Lupatadine has dual antagonistic effect, which can play an obvious antagonistic effect on histamine H1 receptor and platelet activating factor receptor. It is a new type of anti allergic drug, which can effectively inhibit inflammation in all stages of allergic reaction. This drug has the characteristics of rapid onset and long-lasting effect. It is recommended to take orally once a day in clinical application. Clinical studies have shown that oral low-dose of lupatadine can effectively relieve the symptoms of seasonal and perennial allergic rhinitis. With the deepening of relevant research in recent years, it has been found that lupatadine has good therapeutic effect on skin diseases such as chronic urticaria, and patients have better tolerance to this drug. In this paper, through the relevant literature review, summarize and analyze the new progress of pharmacodynamics and application of lupatadine, mainly from the drug effect and clinical application.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
